Delivery Order SPE2DB20D2104-SPE2DB25FMZZQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order carries a ceiling value of $1,269.01 and has an ultimate completion date of August 19, 2025. The contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,250.17 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Nexletol 180 mg on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nexletol 180 mg tablets (30-unit packaging) valued at $1,389.23. This competitively awarded, firm fixed-price delivery order is non-set-aside and has a completion date of July 31, 2025. The award is issued to AmerisourceBergen Drug Corp's Corporate Office, with performance taking place at the company's Conshohocken, Pennsylvania headquarters, which serves as a major hub for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) on September 2, 2025, with a ceiling value of $2,667.56 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.43 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-unit package) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. As a child contract action under AmerisourceBergen's larger contract vehicle, this delivery order fulfills...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,727.88 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET, with an ultimate completion date of August 1, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,342.52, is for the supply of NEXLETOL 180 MG TABLET medical products. It is a firm fixed-price contract with a period of performance through November 7, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a $1,487.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets in quantities of 30, with an ultimate completion date of July 28, 2025. This non-competitive, non-set-aside delivery order was issued on July 25, 2025, and represents a routine pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award is a $3,453.94 delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The delivery order is for the supply of NEXLETOL 180 MG TABLET, a specialty pharmaceutical product, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZZQDelivery Order
The Defense Logistics Agency awarded a $1,988.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves military and veteran healthcare systems through a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/10/25 |